Search For "drug administration"
Trump calls FDA plan to tighten guidelines for COVID-19 vaccine approval '
Updated : 5 years, 5 months ago IST
Washington [US], September 24 (ANI/Sputnik): US President Donald Trump ON Wednesday (local time) said that his administration may or may not approve a proposal from the Food and Drug Administration (FDA) that would tighten guidelines for approving a novel coronavirus disease (COVID-19) vacci
Read More
West Begins Warehousing Operations in Chennai, India
Updated : 5 years, 6 months ago IST
Chennai (Tamil Nadu) [India], Aug 25 (ANI/NewsVoir): West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the official opening of its warehousing operations in Chennai, India. The warehouse in Sriperumbudu
Read More
Equity indices trade higher, Eicher Motors top gainer
Updated : 5 years, 6 months ago IST
Mumbai (Maharashtra) [India], Aug 24 (ANI): Equity benchmark indices traded on a positive note during early hours on Monday led by gains in financial and auto stocks.
Read More
Trump announces emergency authorization of convalescent plasma to treat C
Updated : 5 years, 6 months ago IST
Washington D.C. [US], August 24 (ANI): The US Food and Drug Administration (FDA) has authorised the use of convalescent plasma for the treatment of COVID-19 patients.
Read More
Trump slams FDA for slowing down human trials of COVID-19 vaccine
Updated : 5 years, 6 months ago IST
Washington [US], Aug 23 (ANI): US President Donald Trump on Saturday (local time) slammed the Food and Drug Administration (FDA) for trying to slow down the human trials of coronavirus vaccines.
Read More
COVID-19: 3 Indian companies start supply of life-saving Remdesivir to Nep
Updated : 5 years, 6 months ago IST
Kathmandu [Nepal], August 21 (ANI): Three Indian pharmaceutical companies have started supplying Nepal with life-saving anti-viral Remdesivir to be used for the treatment of COVID-19 patients.
Read More
US authorises use of saliva test for COVID-19: FDA
Updated : 5 years, 7 months ago IST
Washington [US], August 16 (ANI/Sputnik): The United States' Food and Drug Administration (FDA) has approved a new COVID-19 testing method based on analysing saliva samples.
Read More
Jubilant launches Remdesivir in India for treatment of COVID-19
Updated : 5 years, 7 months ago IST
Noida (Uttar Pradesh) [India], Aug 4 (ANI): Jubilant Life Sciences has launched Remdesivir for injection under the brand name JUBI-R in Indian market at a price of Rs 4,700 per vial of 100 mg and said it will make the drug available to over 1,000 hospitals providing COVID-19 treatment throug
Read More
FDA issues first emergency use authorisation for COVID-19 pool testing
Updated : 5 years, 7 months ago IST
Washington D.C. [USA], July 19 (ANI): The US Food and Drug Administration (FDA) on Saturday (local time) issued an emergency use authorisation (EUA) to Quest Diagnostics that allows pool samples from up to four individuals to test for COVID-19.
Read More
Indian pharma compliance standards improving, regulatory risks here to sta
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 7 (ANI): Indian pharmaceutical companies have built a strong abbreviated new drug application (ANDA) pipeline since FY12 through scaling-up of investments in R&D but this will increase the inspection intensity, India Ratings and Research (Ind-Ra) said o
Read More
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per via
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.
Read More
US approved 4 COVID-19 vaccine candidates for clinical trials - FDA Head
Updated : 5 years, 8 months ago IST
Washington [US], July 1 (Sputnik/ANI): The United States has approved four coronavirus vaccine candidates for clinical trials, Food and Drug Administration (FDA) head Stephen Hahn told reporters.
Read More